Search filters

Filters
Clear All

Phase

  • 3
  • 4
  • 3
  • 6
  • 2
  • 11
  • 2
  • 38
  • 71
  • 22
  • 4
  • 67

Found 71 Menstruation trials

A listing of Menstruation medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:
22 years - 75 years
All genders
Phase 1
This dual-site, double-blinded, randomized, sham-controlled, crossover study is to assess the safety, feasibility, and preliminary efficacy of SEEG-guided multi-lead DBS in 10 participants suffering from severe symptoms of chronic, treatment-refractory OCD. Stage 1: Invasive SEEG Monitoring and Recovery Goal: To perform stimulation mapping studies and SEEG recordings, that aid in …
Test Trial for Go-Live 1 - V7.3 smoketesting
55 years - 100 years
All genders
Test Trial for Go-Live for data migration - testExclusion Criteria:The presence of any active, known, or suspected autoimmune disease. Type 1 diabetes, which was admitted to receive stable dose of insulin, hypothyroidism, which required only hormone replacement therapy, skin disease with no need to systemic treatment and no acute exacerbation …
99 years or below
All genders
PURPOSE We aim to conduct a prospective observational study to test the central hypothesis that myocardial LM begins early after STEMI, as a response to myocardial hemorrhage and reperfusion injury, and determines future susceptibility to malignant arrhythmia. Study participants will be 175 (allowing for 25 dropouts) men and women 2 …
18 years - 100 years
All genders
Phase 3
Interventional
The purpose of this study is to investigate primary immune thrombocytopenia. This study evaluates how well the investigational medication works with corticosteroids in maintaining platelet count in adults.The study focuses on assessing the safety and effectiveness of the investigational medication in comparison to a placebo. It evaluates how the treatment …
6 years or above
All genders
Phase 3
Interventional
This study investigates X-linked retinoschisis (XLRS).The purpose of this study is to evaluate the safety and effectiveness of an investigational medication.Who can participate: Participants must be 6 years or older and have a clinical diagnosis of XLRS due to RS1 mutations. Both males and females with specific genetic criteria can …
25 years - 60 years
Accepts healthy volunteer
All genders
This study investigates the effects of central nervous system (CNS) stressors in a controlled environment. The purpose of this study is to understand how these stressors might impact individuals during spaceflight.The study focuses on evaluating the impairing effects of sleep deprivation and alcohol consumption on cognitive and sensorimotor performance. It …
18 years - 75 years
All genders
Phase 3
The study is designed to evaluate the efficacy and safety of brenipatide verse placebo in adults with mild alcohol use disorder (AUD). This study will investigate the effects of brenipatide across a wide dose range to inform further clinical development of the molecule for the treatment of AUD.
Effect of GLP-1 Agonist Therapy on Insulin Secretion in Adults with Pancreatic Insufficient Cystic Fibrosis and Abnormal Glucose Tolerance: a randomized  open-label  cross-over trial
18 years - 50 years
All genders
The research study is being conducted to better understand Cystic-Fibrosis Related Diabetes (CFRD) and to see the effects of an analog of the gut incretin hormone, GLP-1 (dulaglutide), has on individuals like with abnormal glucose tolerance. GLP-1 (dulaglutide) helps the pancreas release insulin, which controls blood sugar levels from getting …
18 years or above
All genders
Observational
This study investigates psoriatic arthritis (PsA) and spondyloarthritis (SpA).The study evaluates the safety and effectiveness of approved treatments for these conditions.Who can participate: Adults 18 years or older with joint conditions can join. Participants must not have other autoimmune inflammatory arthritis and should not be in a clinical trial for …
AOC 1001-CS3 HARBOR
18 years - 65 years
All genders
Phase 3
This is a phase 3 trial of AOC 1001, an antibody-oligonucleotide conjugate. Protocol includes participants ages 16-65 with a clinical and genetic diagnosis of DM1 with DMPK CTG repeat length greater than or equal to 100; Penn site will enroll ages 18 to 65 years only. Participants will be randomized …